Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05385705
What this trial is testing

Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020

Who this might be right for
Breast Neoplasms
Vall d'Hebron Institute of Oncology 2
Testing effectiveness (Phase 2)UnknownNCT03242603
What this trial is testing

Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells

Who this might be right for
Neuroblastoma Recurrent
National University Hospital, Singapore 5
Not applicableStudy completedNCT00002296
What this trial is testing

The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease

Who this might be right for
Lymphatic DiseaseHIV Infections
Newport Pharmaceuticals International
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Not applicableUnknownNCT00173758
What this trial is testing

The Expression of IL-15 and Its Receptor in Decidua

Who this might be right for
PregnancyInfertility
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04836390
What this trial is testing

Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Michael Pulsipher 30
Testing effectiveness (Phase 2)Study completedNCT01370213
What this trial is testing

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 25
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Not applicableNot Yet RecruitingNCT07249476
What this trial is testing

Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia

Who this might be right for
Leukaemia (Acute Myeloid)Leukaemia (Acute Lymphoblastic)Myelodysplastic Syndrome
Nantes University Hospital 55
Not applicableStudy completedNCT00824889
What this trial is testing

Exploratory Study of Natural Killer Cells in Human Skin

Who this might be right for
Atopic DermatitisContact DermatitisPsoriasis+3 more
Assistance Publique Hopitaux De Marseille 28
Very early researchUnknownNCT05194709
What this trial is testing

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Wuxi People's Hospital 40
Post-approval studies (Phase 4)UnknownNCT01501149
What this trial is testing

Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ

Who this might be right for
Nasal and Nasal-type NK/T-cell Lymphoma
Mingzhi Zhang 80
Early research (Phase 1)Looking for participantsNCT06821685
What this trial is testing

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Who this might be right for
Abortion, HabitualInfertility UnexplainedEmbryo Implantation+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 14
Not applicableUnknownNCT05258643
What this trial is testing

The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study

Who this might be right for
Complement AbnormalityPeripheral Blood Mononuclear CellsCovid19
Universitair Ziekenhuis Brussel 150
Not applicableStudy completedNCT01172015
What this trial is testing

NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults

Who this might be right for
Immunologic Thrombcytopenic Purpura (ITP) Adults
Assistance Publique Hopitaux De Marseille 80
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Not applicableUnknownNCT01801852
What this trial is testing

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Chinese PLA General Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03499834
What this trial is testing

Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) Stage IV
Ivy Life Sciences, Co., Ltd 26
Early research (Phase 1)Active Not RecruitingNCT00336063
What this trial is testing

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaRecurrent Nasopharyngeal Keratinizing Squamous Cell CarcinomaRecurrent Nasopharyngeal Undifferentiated Carcinoma+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02562963
What this trial is testing

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

Who this might be right for
Non-small Cell Lung CancerGastric CancerHepatocellular Carcinoma+1 more
Minghui Zhang 120
Next Page
18